Effectiveness and Safety of Nonvitamin K Oral Anticoagulants Rivaroxaban and Apixaban in Patients with Venous Thromboembolism: A Meta-Analysis of Real-World Studies

BACKGROUND: Rivaroxaban and apixaban are the most widely used nonvitamin K oral anticoagulants (NOACs) in patients with venous thromboembolism (VTE). This meta-analysis evaluates the effectiveness and safety of both NOACs versus standard of care (SoC) in real-world practice. METHODS: Real-world evid...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Olivia, Morris, Stephen, Larsen, Torben Bjerregaard, Skjøth, Flemming, Evans, Alex, Bowrin, Kevin, Wojciechowski, Piotr, Margas, Wojciech, Huelsebeck, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203223/
https://www.ncbi.nlm.nih.gov/pubmed/35801133
http://dx.doi.org/10.1155/2022/2756682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203223/
https://www.ncbi.nlm.nih.gov/pubmed/35801133
http://dx.doi.org/10.1155/2022/2756682

Ejemplares similares